MedicaidPrior AuthMedium impact
Pharmacy Program Updates January 2024
Alaska Medicaid·AK · Pharmacy, Oncology, Pain Management +1 more·Pharmacy
Effective date
Mar 1, 2024
We identified it
Jun 21, 2026
Summary
Alaska Medicaid updated their Preferred Drug List and prior authorization requirements effective March 1, 2024. 22 new medications were added to the interim prior authorization list requiring prior auth, while 15 medications (including buprenorphine/naloxone and several oncology drugs) were removed from prior authorization requirements.
Action Required
Before March 1, 2024: Billing team must update prior authorization requirements in billing system for 22 new medications (including Xphozah, Bexaglifozin, Xalkori Pellet, and others listed). Remove prior authorization requirements for 15 medications including buprenorphine/naloxone and oncology drugs (Piqray, Ayvakit, Tagrisso, etc.). Update pharmacy prior authorization forms from Alaska Medicaid website. Verify ICD-10 codes continue to be required for C-II opioid prescriptions and that MME levels exceeding 150 require prior authorization.